Search for: "Files v. King et al" Results 161 - 180 of 319
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
4 Jun 2012, 7:53 pm by Matthew Bush
Petition for certiorari Brief in oppositionAmicus brief of United Retired Firefighters Association and The American Legion Department of CaliforniaAmicus brief of Foundation for Moral LawAmicus brief of American Center for Law and Justice et al.Amicus brief of Texas et al.Amicus brief of David EpsteinAmicus brief of Family Research Council et al.Amicus brief of Rear Admiral Jeremiah Denton, USN (Ret.) et al.Motion of Pacific Justice Institute to withdraw motion to… [read post]
16 Jan 2012, 4:07 pm by Lyle Denniston
   The application, Tennant, et al., v. [read post]
31 Jan 2023, 1:01 pm by Florian Mueller
Microsoft asks the court to adjudge its motion to dismiss regardless of any commitments not to close the deal before a given date.Here's Microsoft's motion, filed late Tuesday afternoon Pacific Time:De Martini et al. v. [read post]
1 Oct 2007, 8:03 am
Reynolds, et al. -- immunity of wholesale discount prices to challenge under Robinson-Patman Act solely because they are available to all buyers. 06-1617, Gilles v. [read post]
9 Mar 2011, 3:00 am by Marie Louise
Bayer AG  (FDA Law Blog) (Patent Docs) Dexilant (Dexlansoprazole) – US: Takeda files patent infringement suit against Handa following Para IV certification filing (Patent Docs) EpiPen – US: Orange Book patent delisting counterclaim raised in 505(b)(2) application patent infringement litigation; decision could provide guidance on drug delivery system patent listability: King Pharmaceuticals v Intelliject (FDA Law Blog) Fentora (Fentanyl)… [read post]